The stock has been placed in Graded Surveillance Measure (GSM) list GSM - IV.

Sarda Proteins Ltd.

BSE: 519242

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Edible Oil

97.78+0.0 (+0.00%)

27 Jul, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Sarda Proteins Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	TTM Jun 30

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	5.63	7.15	5.40	11.36	10.76	5.80	1.30	24.19	18.20
Cost of Operating Revenue	5.49	7.03	5.13	10.98	10.29	5.72	1.21	23.91	13.90
Gross Profit	0.14	0.11	0.27	0.38	0.47	0.08	0.09	0.28	4.30
Gross Margin	2.5	1.6	5.0	3.3	4.4	1.3	6.8	1.2	23.6
Total Operating Expenses	5.99	7.26	5.23	11.30	10.40	5.78	1.28	24.17	20.68
Operating Profit	-0.35	-0.11	0.17	0.06	0.36	0.01	0.02	0.02	-2.48
Operating Margin	-6.3	-1.6	3.2	0.5	3.3	0.2	1.5	0.1	-13.7
Financing Income/(Expense) - Net	0.00	0.00	0.00	0.00	0.00	-	0.00	-	-
Profit before Taxes	-0.37	-0.09	0.17	0.06	0.35	0.01	0.02	0.02	3.34
Income Taxes	-0.04	0.04	0.14	0.08	0.05	0.05	0.00	0.02	0.55
Profit after Tax	-0.33	-0.12	0.03	-0.02	0.31	-0.03	0.02	0.01	2.79
PAT Margin	-5.9	-1.7	0.6	-0.2	2.9	-0.6	1.5	-	15.3
EPS - Basic - ex Extraordinary Items	-1.92	-0.72	0.19	-0.12	1.78	-0.19	0.11	0.03	8.41
EPS - Diluted - ex Extraordinary Items	-1.92	-0.72	0.19	-0.12	1.78	-0.19	0.11	0.03	8.41
EBIT	-0.35	-0.11	0.17	0.06	0.36	0.01	0.02	0.02	-2.48
EBITDA	-0.34	-0.11	0.17	0.06	0.36	0.01	0.02	0.02	-2.48
EBITDA Margin	-6.1	-1.5	3.2	0.6	3.3	0.2	1.5	0.1	-13.7

Balance Sheet

Abridged

Understanding Balance Sheet

Sarda Proteins Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	1.76	1.76	1.84	1.90	2.27	2.27	2.30	2.53
Long-Term Investments	0.01	0.00	0.00	0.00	0.00	0.00	-	-
Property Plant & Equipment - Net	0.03	0.02	0.01	0.01	0.00	0.00	0.00	-
Total Non-Current Assets	0.56	0.43	0.31	0.23	0.18	0.14	0.14	0.12
Total Assets	2.32	2.19	2.15	2.13	2.45	2.40	2.43	2.65
Total Current Liabilities	0.04	0.03	0.04	0.03	0.04	0.02	0.02	0.24
Long Term Debt	-	-	-	-	-	-	-	0.03
Total Non-Current Liabilities	0.09	0.10	0.01	0.02	0.03	0.03	0.04	0.03
Total Liabilities	0.13	0.13	0.05	0.05	0.07	0.05	0.06	0.27
Total Shareholders' Equity	2.19	2.07	2.10	2.08	2.39	2.35	2.37	2.38
Total Equity	2.19	2.07	2.10	2.08	2.39	2.35	2.37	2.38
Total Liabilities & Equity	2.32	2.19	2.15	2.13	2.45	2.40	2.43	2.65

Cash Flow

Abridged

Understanding Cash Flow Statement

Sarda Proteins Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	-0.34	-0.11	0.15	0.05	0.36	0.01	0.02	0.02
Working Capital - Increase/(Decrease)	0.83	-0.41	-0.12	-0.02	-0.17	-0.15	-0.09	-0.13
Net CF from Operating Activities	0.50	-0.52	0.03	0.03	0.19	-0.14	-0.07	-0.11
Capital Expenditures - Net	0.00	-	-0.01	-	0.00	-	0.00	0.00
Net CF from Investing Activities	0.00	0.04	0.01	-	0.00	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-0.20	0.01	-0.01	-	-	-	-	0.03
Net Cash Flow from Financing Activities	-0.20	0.01	-0.01	-	-	-	-	0.03
Free Cash Flow to Equity	0.30	-0.51	0.03	0.03	0.19	-0.14	-0.07	-0.08
Free Operating CF net dividend	0.48	-0.52	0.03	0.03	0.19	-0.14	-0.07	-0.11
Free Operating CF	0.48	-0.52	0.03	0.03	0.19	-0.14	-0.07	-0.11

Business Segment Analysis

Sarda Proteins Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Sarda Proteins Ltd.

Regional Segment Analysis

Sarda Proteins Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Sarda Proteins Ltd.

Historical Segment Analysis

Track how Sarda Proteins Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Sarda Proteins Ltd.

Frequently Asked Questions

What is the revenue of Sarda Proteins Ltd.?

The latest trailing twelve month revenue of Sarda Proteins Ltd. is ₹ 18.20 Cr, reflecting a 1-year growth of -48.22% and a 3-year CAGR of 44.50%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Sarda Proteins Ltd.?

The latest trailing twelve month net profit (PAT) of Sarda Proteins Ltd. is ₹ 2.79 Cr, with a 3-year earnings CAGR of -74.48%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Sarda Proteins Ltd.?

The trailing twelve month EBITDA of Sarda Proteins Ltd. is approximately ₹ -2.48 Cr (based on an operating margin of -13.66%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Sarda Proteins Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Sarda Proteins Ltd. is 8.41. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Sarda Proteins Ltd.?

The debt-to-equity ratio of Sarda Proteins Ltd. stands at 0.07. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Sarda Proteins Ltd.?

The estimated book value per share of Sarda Proteins Ltd. is 13.26 (derived from a P/B ratio of 7.37 and market price of ₹ 97.78), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Sarda Proteins Ltd.?

The trailing twelve month operating cash flow of Sarda Proteins Ltd. is ₹ -82.71 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Sarda Proteins Ltd. report consolidated or standalone financials?

Sarda Proteins Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.